Lates News

Hong Kong-listed innovative pharmaceutical sector continued to decline, BeiGene and Gilead Sciences-B both fell more than 10%, Innovent Biologics fell more than 7%, Chia Tai Tianqing Pharmaceutical and Shiyao Group led the decline.